Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Survival Tree01:19

Survival Tree

132
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
132
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

413
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
413
Cancer02:18

Cancer

49.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope.

Nature communications·2025
Same author

Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope.

Nature communications·2024
Same author

Scuphr: A probabilistic framework for cell lineage tree reconstruction.

PLoS computational biology·2024
Same author

Spatial transcriptomics of B cell and T cell receptors reveals lymphocyte clonal dynamics.

Science (New York, N.Y.)·2023
Same author

Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics.

Nature communications·2023
Same author

Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction.

Proceedings of the National Academy of Sciences of the United States of America·2022

Related Experiment Video

Updated: Aug 19, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.3K

ToMExO: A probabilistic tree-structured model for cancer progression.

Mohammadreza Mohaghegh Neyshabouri1,2, Jens Lagergren1,2

  • 1Department of Electrical Engineering and Computer Science, KTH Royal Institute of Technology, Stockholm, Sweden.

Plos Computational Biology
|December 5, 2022
PubMed
Summary

This study introduces ToMExO, a novel algorithm for analyzing cancer driver gene mutations. It models mutation accumulation as a tree to reveal cancer-specific mutation patterns and gene relationships.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

27.0K

Related Experiment Videos

Last Updated: Aug 19, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

27.0K

Area of Science:

  • Genomics
  • Computational Biology
  • Cancer Research

Background:

  • Understanding cancer driver gene interactions is crucial for cancer research.
  • Identifying mutation patterns and their temporal order is key to deciphering cancer progression.

Purpose of the Study:

  • To develop a method for identifying cancer-type-specific mutation accumulation processes.
  • To model the temporal order and mutual exclusivity of driver gene mutations.
  • To analyze large-scale cancer genomic datasets.

Main Methods:

  • Utilizing a tree-based model to represent driver gene mutation accumulation.
  • Developing a computationally efficient dynamic programming approach for likelihood calculation.
  • Implementing a Markov Chain Monte Carlo (MCMC) inference algorithm named ToMExO.
  • Employing engineered MCMC moves for efficient analysis of large datasets.

Main Results:

  • ToMExO successfully models mutual exclusivity and temporal order of mutations.
  • The algorithm demonstrates superior performance on synthetic and biological datasets compared to state-of-the-art methods.
  • Analysis of colorectal cancer, glioblastoma, and pancreatic cancer datasets revealed significant and valid patterns.
  • Results were validated using method-independent metrics for causality and significance.

Conclusions:

  • ToMExO provides an efficient and accurate method for analyzing cancer driver gene mutations.
  • The algorithm can handle large datasets, overcoming limitations of existing methods.
  • This work advances the understanding of cancer progression dynamics and gene interrelations.